Postmarketing surveillance for dog and cat vaccines: New resources in changing times

Journal of the American Veterinary Medical Association

Volumn 227, Issue 7, 2005, Pages 1066-1069

  Moore, George E ^a   Frana, Timothy S ^b   Guptill, Lynn F ^a   Ward, Michael P ^a,d   Lewis, Hugh B ^c   Glickman, Lawrence T ^a  

^a PURDUE UNIVERSITY   (United States)

^b UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

^c Banfield Pet Hospital   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

CAT; COST EFFECTIVENESS ANALYSIS; DATA BASE; DOG; DRUG APPROVAL; DRUG INDUSTRY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; HIGH RISK POPULATION; MEDICAL LITERATURE; NOTE; POSTMARKETING SURVEILLANCE; RISK FACTOR; VACCINE PRODUCTION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; PRODUCT SURVEILLANCE, POSTMARKETING; QUALITY CONTROL; SAFETY; UNITED STATES; VACCINATION; VACCINES;

CANIS FAMILIARIS;

EID: 26044463470     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.227.1066     Document Type: Note

References (22)

1. Animal and Plant Health Inspection Service. Veterinary Services Memorandum No. 800.204. USDA, May 28, 2002.
2. Siev D. An introduction to analytical methods for the post-marketing surveillance of veterinary vaccines. Adv Vet Med 1999; 41:749-774.
3. Meyer EK. Vaccine-associated adverse events. Vet Clin North Am Small Anim Pract 2001;31:493-514.
4. Chen RT. Special methodological issues in pharmacoepidemiology studies of vaccine safety. In: Strom BL, ed. Pharmacoepidemiology. 3rd ed. West Sussex, England: John Wiley & Sons, 2000;707-732.
5. Salmon DA, Moulton LH, Halsey NA. Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety. Am J Public Health 2004;94:947-950.
6. USDA Center for Veterinary Biologies. Adverse event reporting. Available at: www.aphis.usda.gov/vs/cvb/ic/adverseeventreport.htm. Accessed Jan 5, 2005.
7. Chen RT, Rastogi SC, Mullen JR, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994;12:542-550.
8. Title 9 Code of Federal Regulations, part 116.5. US Government Printing Office, Jan 1, 2004.
9. Meyer EK, Becker SC. The United States Pharmacopeia Veterinary Practitioners' Reporting Program. J Am Vet Med Assoc 1996;208:361-363.
10. U.S. Pharmacopeia to close Veterinary Practitioners' Reporting Program. J Am Vet Med Assoc 2003;222:1326.
11. United States Government. Proposed rules: 9 CFR parts 101 and 116. Fed Regist 2002;67:1910-1913.
12. Miller E, Waight P, Farrington P. Safety assessment postlicensure. Dev Biol Stand 1998;95:235-243.
13. Wilbur LA, Evermann JF, Levings RL, et al. Abortion and death in pregnant bitches associated with a canine vaccine contaminated with bluetongue virus. J Am Vet Med Assoc 1994;204:1762-1765.
14. Varricchio F, Iskander J, Destefano F et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004;23:287-294.
15. Wallenstein EJ, Fife D. Temporal patterns of NSAID spontaneous adverse event reports: the Weber effect revisited. Drug Saf 2001;24:233-237.
16. Evans SJ. Pharmacovigilance: a science or fielding emergencies? Stat Med 2000;19:3199-3209.
17. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology: the essentials. 3rd ed. Baltimore: The Williams & Wilkins Co, 1996.
18. Glickman LT. Weighing the risks and benefits of vaccination. Adv Vet Med 1999;41:701-713.
19. Moore GE, Glickman NW, Ward MP, et al. Incidence of and risk factors for adverse events associated with distemper and rabies vaccine administration in ferrets. J Am Vet Med Assoc 2005;226:909-912.
20. Moore GE, Guptill LF, Ward MP, et al. Adverse events diagnosed within three days of vaccine administration in dogs. J Am Vet Med Assoc 2005;227:1102-1108.
21. Strom BL, Carson JL. Use of automated databases for pharmacoepidemiology research. Epidemiol Rev 1990;12:87-107.
22. Ellenberg SS, Braun MM. Monitoring the safety of vaccines: assessing the risks. Drug Saf 2002;25:145-152.